| [1]MOBLEY A S,RODRIGUEZ-GIL D J,IMAMURA F,et al.Aging in the olfactory system[J].Trends Neurosci,2014,37(2):77-84.
[2]GOPINATH B,SUE C M,KIFLEY A,et al.The association between olfactory impairment and total mortality in older adults[J].J Gerontol A Biol Sci Med Sci,2012,67(2):204-209.
[3]WILSON R S,ARNOLD S E,TANG Y,et al.Odor identification and decline in different cognitive domains in old age[J].Neuroepidemiology,2006,26(2):61-67.
[4] POSTUMA R B,BERG D,STERN M,et al.MDS clinical diagnostic criteria for Parkinson’s disease[J].Mov Disord,2015,30(12):1591-1601.
[5]WARD C D,HESS W A,CALNE D B.Olfactory impairment in Parkinson’s disease[J].Neurology,1983,33(7):943-946.
[6]QUINN N P,ROSSOR M N,MARSDEN C D.Olfactory threshold in Parkinson’s disease[J].J Neurol Neurosurg Psychiatry,1987,50(1):88-89.
[7] MILLAR VERNETTI P,ROSSI M,CERQUETTI D,et al.Comparison of olfactory identification patterns among Parkinson’s disease patients from different countries[J].Chem Senses,2015,41(1):77-83.
[8]YU C Y,WU R M.Application of the University of Pennsylvania Smell Identification Test (traditional Chinese version) for detecting olfactory deficits in early Parkinson’s disease in a Taiwanese cohort[J].J Parkinsons Dis,2013,4(2):175-180.
[9]BRMERSON A,JOHANSSON L,EK L,et al.Prevalence of olfactory dysfunction:the skvde population-based study[J].Laryngoscope,2004,114(4):733-737.
[10]HTTENBRINK K B,HUMMEL T,BERG D,et al.Olfactory dysfunction:common in later life and early warning of neurodegenerative disease[J].Dtsch Arztebl Int,2013,110(1/2):1-7.
[11]KARPA M J,GOPINATH B,ROCHTCHINA E,et al.Prevalence and neurodegenerative or other associations with olfactory impairment in an older community[J].J Aging Health,2010,22(2):154-168.
[12]SCHUBERT C R,CRUICKSHANKS K J,FISCHER M E,et al.Olfactory impairment in an adult population:the Beaver Dam Offspring Study[J].Chem Senses,2012,37(4):325-334.
[13]DOTY R L,KAMATH V.The influences of age on olfaction:a review[J].Front Psychol,2014,5(2):20.
[14]LAFRENIERE D,MANN N.Anosmia:loss of smell in the elderly[J].Otolaryngol Clin North Am,2009,42(1):123-131.
[15]HOYLES K,SHARMA J C.Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease:a pragmatic approach[J].J Neurol,2013,260(12):2951-2958.
[16]ANSARI K A,JOHNSON A.Olfactory function in patients with Parkinson’s disease[J].J Chronic Dis,1975,28(9):493-497.
[17]BOHNEN N I,GEDELA S,HERATH P,et al.Selective hyposmia in Parkinson disease:association with hippocampal dopamine activity[J].Neurosci Lett,2008,447(1):12-16.
[18]BRAAK H,DEL TREDICI K,BRATZKE H,et al.Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages)[J].J Neurol,2002,249 (Suppl 3):Ⅲ/1-5.
[19]REY N L,PETIT G H,BOUSSET L,et al.Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice[J].Acta Neuropathol,2013,126(4):555-573.
[20]FREUNDLIEB N,FRANQOIS C,TAND D,et al.Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates[J].J Neurosci,2006,26(8):2321-2325.
[21]HGLINGER G U,RIZK P,MURIEL M P,et al.Dopamine depletion impairs precursor cell proliferation in Parkinson disease[J].Nat Neurosci,2004,7(7):726-735.
[22]WINNER B,DESPLATS P,HAGL C,et al.Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model[J].Exp Neurol,2009,219(2):543-552.
[23]ZHANG S,XIAO Q,LE W.Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein[J].PLoS One,2015,10(3):e0119928.
[24]BOHNEN N I,MLLER M L,KOTAGAL V,et al.Olfactory dysfunction,central cholinergic integrity and cognitive impairment in Parkinson’s disease[J].Brain,2010,133(6):1747-1754.
[25]TAKEDA A,BABA T,KIKUCHI A,et al.Olfactory dysfunction and dementia in Parkinson’s disease[J].J Parkinsons Dis,2013,4(2):181-187.
[26]WU X,YU C,FAN F,et al.Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson’s disease[J].Eur Neurol,2011,66(2):98-105.
[27] KORTEN J J,MEULSTEE J.Olfactory disturbances in Parkinsonism[J].Clin Neurol Neurosurg,1980,82(2):113-118.
[28]BRAAK H,DEL TREDICI K,RB U,et al.Staging of brain pathology related to sporadic Parkinson’s disease[J].Neurobiol Aging,2003,24(2):197-211.
[29]ROSS G W,PETROVITCH H,ABBOTT R D,et al.Association of olfactory dysfunction with risk for future Parkinson’s disease[J].Ann Neurol,2008,63(2):167-173.
[30]BERENDSE H W,BOOIJ J,FRANCOT C M,et al.Subclinical dopaminergic dysfunction in asymptomatic Parkinson’s disease patients’ relatives with a decreased sense of smell[J].Ann Neurol,2001,50(1):34-41.
[31]DOTY R L,DEEMS D A,STELLAR S.Olfactory dysfunction in parkinsonism:a general deficit unrelated to neurologic signs,disease stage,or disease duration[J].Neurology,1988,38(8):1237-1244.
[32]DOTY R L,STERN M B,PFEIFFER C,et al.Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease[J].J Neurol Neurosurg Psychiatry,1992,55(2):138-142.
[33]SAIFEE T,LEES A J,SILVEIRA-MORIYAMA L.Olfactory function in Parkinson’s disease in ON versus OFF states[J].J Neurol Neurosurg Psychiatry,2010,81(11):1293-1295.
[34]ROSSI M,PEREZ-LLORET S,MILLAR VERNETTI P,et al.Olfactory dysfunction evaluation is not affected by comorbid depression in Parkinson’s disease[J].Mov Disord,2015,30(9):1275-1279.
[35]TUNC S,GRAF J,TADIC V,et al.A population-based study on combined markers for early Parkinson’s disease[J].Mov Disord,2015,30(4):531-537.
[36]SENGOKU R,MATSUSHIMA S,BONO K,et al.Olfactory function combined with morphology distinguishes Parkinson’s disease[J].Parkinsonism Relat Disord,2015,21(7):771-777.
[37]PASCHEN L,SCHMIDT N,WOLFF S,et al.The olfactory bulb volume in patients with idiopathic Parkinson’s disease[J].Eur J Neurol,2015,22(7):1068-1073.
[38] LUCASSEN E B,STERLING N W,LEE E Y,et al.History of smoking and olfaction in Parkinson’s disease[J].Mov Disord,2014,29(8):1069-1074.
[39] SHARER J D,LEON-SARMIENTO F E,MORLEY J F,et al.Olfactory dysfunction in Parkinson’s disease:positive effect of cigarette smoking[J].Mov Disord,2015,30(6):859-862.
[40]CHIU W H,DEPBOYLU C,HERMANNS G,et al.Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson’s disease[J].Neuropharmacology,2015,95:367-376.
[41]CHIU S L,CHEN C M,CLINE H T.Insulin receptor signaling regulates synapse number,dendritic plasticity,and circuit function in vivo[J].Neuron,2008,58(5):708-719.
[42]STENSLIK M J,POTTS L F,SONNE J W,et al.Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson’s disease[J].J Neurosci Methods,2015,251(15):120-129.
[43]DANIELYAN L,SCHFER R,VON AMELN-MAYERHOFER A,et al.Intranasal delivery of cells to the brain[J].Eur J Cell Biol,2009,88(6):315-324. |